Innovent, first Chinese biotech firm to market weight-loss drug, joins Hang Seng Index
Innovent Biologics will join the Hang Seng Index next month in the latest quarterly review as the compiler of the
Read MoreInnovent Biologics will join the Hang Seng Index next month in the latest quarterly review as the compiler of the
Read More